IGF1 and endometrial cancer: In endometrial cancer, metformin decreases cell viability and proliferation in a human endometrial cancer cell line (Ishikawa cells) through activation of pAMPK, induction of beclin 1, down-regulation of IGF, and increased autophagy and apoptosis (92).